AlphaYou
Overview
Smart money at a glance
Filings to Oct 1, 2026Net selling: insiders sold $12.4M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$12.4M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 2 added, 1 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Key stats
Fundamentals Oct 1- Open
- $31.64
- 52-wk high
- $33.66
- High
- $32.33
- 52-wk low
- $14.19
- Low
- $30.82
- Prev close
- $31.75
- Mkt cap
- $8.92B
- P/E
- 3.3x
- Volume
- 3.69M
- Fwd P/E
- 43.3x
- P/S
- 9.0x
- P/B
- 15.1x
- Profit margin
- +10.6%
- Op margin
- +10.2%
- ROE
- +20.1%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about CAI filings
Are insiders buying or selling Caris Life Sciences, Inc. Common Stock (CAI) stock?
Net selling: insiders sold $12.4M and bought $0 of CAI stock on the open market in the 90 days to Oct 1, 2026, according to SEC Form 4 filings. The largest was Brille, Brian J (See Remarks), who sold $12.1M. The latest filing was on Sep 23, 2026.
Which members of Congress have traded CAI recently?
None. No member of Congress disclosed a CAI trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this CAI smart-money data?
This summary uses filings available on Oct 1, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders are trading both ways.
What funds are doing
Buys/Adds (2)
- BO
Bank of America
$12.0M
added
- JC
JPMorgan Chase
$61.9M
added
Sells/Trims (1)
- GA
Gotham Asset
$11.7M
trimmed
What insiders are doing
Buys (1)
- HJ
Halbert Jon
$990K
bought
Sells (2)
- DJ
Denton John Russel
$239K
sold
- BB
Brille Brian J
$12.1M
sold
How top traders are positioned
No tracked top-trader positions in CAI right now.
Live Hyperliquid positioning - not every stock is covered
Activist stakes, short interest & more
Earnings
Earnings came in $0.53 a share below what analysts expected.
Earnings per share
-$0.01 expected
Reports Nov 4, 2026, in 34 days
Estimates as of Sep 29, 2026
EPS expected
-$0.01 to $0.07
Revenue expected
12 analysts
Last 30 days
Analysts cutting estimates
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $216.8M | $292.9M | $216.2M | $263.7M |
| Cost of what it sold | $69.3M | $72.0M | $74.8M | $84.1M |
| Gross profit | $147.5M | $220.9M | $141.3M | $179.6M |
| What it spent | ||||
| Research and development | $21.6M | $31.8M | $5.4M | $32.4M |
| Sales and admin | $52.0M | $56.5M | $59.7M | $66.5M |
| Other operating costs | $41.3M | $44.2M | $71.0M | $53.8M |
| Total operating expenses | $114.9M | $132.5M | $136.1M | $152.7M |
| What was left | ||||
| Operating profit | $32.6M | $88.4M | $5.3M | $26.9M |
| Interest on debt | $13.5M | $11.4M | $12.8M | $9.2M |
| Profit before tax | $24.3M | $82.0M | -$644.0K | -$614.0K |
| Tax | — | — | -$134.0K | $23.0K |
| Net profit | $24.3M | $82.0M | -$510.0K | -$637.0K |
| EBITDA | $42.7M | $97.6M | $17.2M | $15.2M |
Technicals
Price structure
This stock is in a strong uptrend, and looks overbought after a fast run-up.
Trend
Strong uptrend
85 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bullish
Caris Life Sciences, Inc. (NASDAQ:CAI) Receives Average Recommendation of "Hold" from Analysts
NeutralSep 23Caris Life Sciences (CAI) director plans 400,000-share sale
NeutralSep 18Caris Life Sciences (NASDAQ: CAI) to Share Investor Presentation Online Following Morgan Stanley Healthcare Conference
Leans bullishSep 16
Macro
35 macro signals shaping CAI right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results